🇺🇸 Pioglitazone + Metformin in United States

34 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Death — 4 reports (11.76%)
  2. Hypoglycaemia — 4 reports (11.76%)
  3. Nausea — 4 reports (11.76%)
  4. Vomiting — 4 reports (11.76%)
  5. Weight Decreased — 4 reports (11.76%)
  6. Diarrhoea — 3 reports (8.82%)
  7. Drug Ineffective — 3 reports (8.82%)
  8. Fatigue — 3 reports (8.82%)
  9. Headache — 3 reports (8.82%)
  10. Acute Kidney Injury — 2 reports (5.88%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is Pioglitazone + Metformin approved in United States?

Pioglitazone + Metformin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Pioglitazone + Metformin in United States?

Sun Yat-sen University is the originator. The local marketing authorisation holder may differ — check the official source linked above.